kalobios pharmaceuticals inc
(KBIO:Consolidated Issue listed on NASDAQ Global Market)
R. Andrew McMillan Ph.D.
Board Observer, KaloBios Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 31 board members in 3 different organizations across 6 different industries.|
See Board Relationships
Dr. R. Andrew McMillan, Ph.D. serves as a Board Observer of Ambrx Inc., Antipodean Pharmaceuticals Inc., KaloBios Inc. and Pearl Therapeutics Inc. Dr. McMillan serves as a Director of Wildcat Discovery Technologies, Inc. He serves as a Board Observer of Achaogen Inc. Dr. McMillan was a Principal at 5AM Ventures since February 20, 2008. He joined 5AM Ventures in 2005 as a Senior Associate. Dr. McMillan was a Principal Investigator in the Bioengineering Branch of NASA. ...
260 East Grand AvenuePhone: 650-243-3100
South San Francisco, California 94080
Board Members Memberships*
Former Board Observer
University Of North Carolina At Chapel Hill
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|